Sheila Gujrathi - Net Worth and Insider Trading
Sheila Gujrathi Net Worth
The estimated net worth of Sheila Gujrathi is at least $4 Million dollars as of 2024-09-20. Sheila Gujrathi is the President & CEO of Gossamer Bio Inc and owns about 4,048,242 shares of Gossamer Bio Inc (GOSS) stock worth over $4 Million. Sheila Gujrathi is also the Director of Ventyx Biosciences Inc and owns about 0 shares of Ventyx Biosciences Inc (VTYX) stock worth over $0. Details can be seen in Sheila Gujrathi's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Sheila Gujrathi has not made any transactions after 2023-03-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Sheila Gujrathi
Sheila Gujrathi Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Sheila Gujrathi owns 5 companies in total, including Turning Point Therapeutics Inc (TPTX) , Gossamer Bio Inc (GOSS) , and Five Prime Therapeutics Inc (FPRX) among others .
Click here to see the complete history of Sheila Gujrathi’s form 4 insider trades.
Insider Ownership Summary of Sheila Gujrathi
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
TPTX | Turning Point Therapeutics Inc | 2019-04-16 | director |
GOSS | Gossamer Bio Inc | 2019-09-27 | director & President & CEO |
FPRX | Five Prime Therapeutics Inc | 2018-05-10 | director |
2021-06-10 | director | ||
2023-03-30 | director |
Sheila Gujrathi Latest Holdings Summary
Sheila Gujrathi currently owns a total of 2 stocks. Among these stocks, Sheila Gujrathi owns 4,048,242 shares of Gossamer Bio Inc (GOSS) as of September 27, 2019, with a value of $4 Million and a weighting of 100%. Sheila Gujrathi also owns 0 shares of Ventyx Biosciences Inc (VTYX) as of March 30, 2023, with a value of $0 and a weighting of 0%.
Latest Holdings of Sheila Gujrathi
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
GOSS | Gossamer Bio Inc | 2019-09-27 | 4,048,242 | 0.96 | 3,886,312 |
VTYX | Ventyx Biosciences Inc | 2023-03-30 | 0 | 2.37 | 0 |
Holding Weightings of Sheila Gujrathi
Sheila Gujrathi Form 4 Trading Tracker
According to the SEC Form 4 filings, Sheila Gujrathi has made a total of 1 transactions in Gossamer Bio Inc (GOSS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Gossamer Bio Inc is the acquisition of 10,000 shares on September 27, 2019, which cost Sheila Gujrathi around $168,000.
According to the SEC Form 4 filings, Sheila Gujrathi has made a total of 1 transactions in Ventyx Biosciences Inc (VTYX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Ventyx Biosciences Inc is the sale of 100,000 shares on March 30, 2023, which brought Sheila Gujrathi around $3 Million.
Insider Trading History of Sheila Gujrathi
- 1
Sheila Gujrathi Trading Performance
GuruFocus tracks the stock performance after each of Sheila Gujrathi's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Sheila Gujrathi is -9.31%. GuruFocus also compares Sheila Gujrathi's trading performance to market benchmark return within the same time period. The performance of stocks bought by Sheila Gujrathi within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Sheila Gujrathi's insider trading performs compared to the benchmark.
Performance of Sheila Gujrathi
Sheila Gujrathi Ownership Network
Sheila Gujrathi Owned Company Details
What does Turning Point Therapeutics Inc do?
Who are the key executives at Turning Point Therapeutics Inc?
Sheila Gujrathi is the director of Turning Point Therapeutics Inc. Other key executives at Turning Point Therapeutics Inc include EVP & Chief Financial Officer Paolo Tombesi , SVP & Chief Commercial Officer Steve M Sabus , and SVP & General Counsel Brian Sun .
Turning Point Therapeutics Inc (TPTX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Turning Point Therapeutics Inc (TPTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Turning Point Therapeutics Inc (TPTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Turning Point Therapeutics Inc (TPTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Turning Point Therapeutics Inc Insider Transactions
Sheila Gujrathi Mailing Address
Above is the net worth, insider trading, and ownership report for Sheila Gujrathi. You might contact Sheila Gujrathi via mailing address: 10835 Road To The Cure, Suite 205, San Diego Ca 92121.